Product Name	Recombinant Rabbit Anti-SALL4 Monoclonal Antibody
Cat No.	SLA0813M
Alias	DRRS; HSAL4; IVIC; ZNF797; 5730441M18Rik; C330011P20Rik; Tex20; SALL4_HUMAN; SALL4; Zinc finger protein 797; Zinc finger protein SALL4; SALL4_MOUSE; spalt like transcription factor 4; sal (Drosophila)-like 4; sal-like 4 (Drosophila)
Host Species	Mouse
Isotype	IgG2b/Kappa
Clonality	Monoclonal
Clone No.	1B7
React Species	Human
Applications	WB (1:500-2000) IHC-P (1:100-500) IHC-F (1:100-500) IF (1:100-500) ELISA (1:5000-10000) Not yet tested in other applications. Optimal working dilutions must be determined by the end user.
Immunogen	Synthesized peptide derived from human SALL4
Purification	affinity purified by Protein G
Concentration	1mg/ml
Predicted MW.	112 kDa
Swiss-Prot	Q9UJQ4
Storage	0.01M TBS (pH7.4) with 1% BSA, 0.02% Proclin300 and 50% Glycerol. Shipped at 4℃. Store at -20℃ for one year. Avoid repeated freeze/thaw cycles.
Background	Sall4 is mammalian homologs of the Drosophila region-specific homeotic gene spalt, which encodes a zinc finger-containing transcription regulator. Drosophila spalt is an essential genetic component required for the specification of posterior head and anterior tail as opposed to trunk. Sall3 is expressed at 24 weeks of gestation in several regions of the human fetal brain including neurons of the hippocampus formation and of mediodorsal and ventrolateral thalamic nuclei, Purkinje cells of the cerebellum, and a subset of neurons in the brainstem. Sall4 expression in early mouse embryos is gradually confined to the head region and the primitive streak, followed by prominent expression in the developing midbrain, branchial arches, limbs and genital papilla.
Attention	This product as supplied is intended for research use only, not for use in human, therapeutic or diagnostic applications.

 

FOR RESEARCH USE ONLY. Not for use in diagnostic or therapeutic procedures.